Please check your internet connection and try again.
# Hyoscine butylbromide (Buscopan)
## Overview
Hyoscine butylbromide is an anticholinergic and antispasmodic agent. It works by blocking muscarinic receptors in the smooth muscle of the gastrointestinal tract, leading to relaxation and reduced spasms. It has limited systemic absorption when given orally, with most of its action occurring locally in the gut.
## Primary Indications
* Symptomatic relief of abdominal pain and cramping associated with gastrointestinal spasms, such as irritable bowel syndrome (IBS).
## Adult Dosing
* **Oral:** 10 mg to 20 mg up to four times daily.
* **Parenteral (Intramuscular/Intravenous):** 20 mg as a single dose. May be repeated every 4-8 hours if necessary. Maximum daily dose is typically 100 mg.
## Pediatric Dosing
* There is limited robust data for pediatric use. Some sources suggest the following:
* **Oral:**
* Ages 6-12 years: 10 mg up to three times daily.
* Younger children: Dosing is not well-established and should be used with caution.
* **Parenteral:** Dosing in children is generally not recommended due to lack of data and potential for adverse effects. If used, specialist consultation is advised.
## Dose Adjustments
* No specific dose adjustments are typically required for hepatic or renal impairment, due to limited systemic absorption. However, caution may be warranted in patients with severe disease.
## Contraindications
* Hypersensitivity to hyoscine butylbromide or any component of the formulation.
* Myasthenia gravis.
* Certain types of glaucoma (e.g., angle-closure glaucoma).
* Megaloblastic anemia (due to potential to interfere with vitamin B12 absorption).
* Tachyarrhythmias.
* Ileus, intestinal atony, paralytic ileus.
* Prostatic hypertrophy with urinary retention.
* Myasthenia gravis.
## Adverse Effects
* **Common:** Dry mouth, blurred vision, constipation, urinary retention, difficulty with accommodation, increased heart rate, drowsiness.
* **Less Common/Rare:** Allergic reactions (including anaphylaxis), urticaria, dyshidrosis, flushing, dizziness, headache, injection site reactions (with parenteral use).
## Key Drug Interactions
* **Other Anticholinergics:** Additive effects, increasing the risk of anticholinergic side effects (e.g., atropine, scopolamine, tricyclic antidepressants, some antihistamines).
* **Dopamine Antagonists:** May reduce the efficacy of prokinetic drugs (e.g., metoclopramide).
* **Medications Affecting Gastric pH:** Antacids and H2 blockers may affect absorption.
## Monitoring
* Monitor for relief of abdominal symptoms.
* Assess for adverse effects, particularly anticholinergic effects (dry mouth, blurred vision, urinary retention, constipation, tachycardia).
* Monitor for signs of hypersensitivity, especially with parenteral administration.
## Clinical Pearls
* Oral formulations have poor systemic bioavailability, making them generally safe for long-term use in appropriate patients.
* Parenteral formulations provide more rapid and potent effects but carry a higher risk of systemic adverse effects.
* The use of hyoscine butylbromide in children is limited, and caution is advised. Consult pediatric guidelines or a specialist if considering use.
* Ensure patients are aware of potential anticholinergic side effects, especially blurred vision and urinary retention.
***
_Please verify current prescribing information with the manufacturer's product monograph or other reliable resources before making any clinical decisions._
